Immudicon

Training the body's immune system to defeat cancer & other deadly diseases.
Immudicon is developing MacroVax, an intracellular vaccine delivery technology, to activate the immune system against cancer and potentially other disease indications. Initial research & trials of our technology have been shown in vitro in both mouse and human ...

Cellanyx Diagnostics

Harnessing the Predictive Power of Biomarkers to Revolutionize Prostate Tumor Treatment
Leveraging a proprietary diagnostic device, assay, and analytics, Cellanyx's testing service will use live-cell analysis of our patent-pending pool of biomarkers from a new and proprietary class of markers. Based on cellular behavior and bio-mechanics rather than ...

GnuBIO

Desktop DNA Sequencing for Diagnostic & Applied Markets
Desktop DNA sequencing system. Low cost, fast turn-around, integrated system. Sample In, Answer Out

Ginkgo Bioworks

The Organism Company
Ginkgo Bioworks engineers organisms to address fundamental challenges the world is facing today. We aren't trying to study biology, we are trying to build it - constructing, editing, and redesigning the living world. Our bioengineers make use of an in-house pipeline ...

Venture Development Center

Boston's leading high tech incubator
Top-tier facilities, mentors and community for exceptional startups in the rapidly-converging worlds of life science, healthcare and information technology.

Blueprint Medicines

Sample6

Gelesis

BioBright

Bringing the biology lab into the digital age
Biological experimentation is cumbersome and often error-prone, leading to enormous inefficiencies throughout the biomedical pipeline. BioBright is developing an "internet of things" platform to make biology easier and more reproducible, allowing experimenters ...

Modeural

Next generation targeted psychotherapeutics
Drug discovery and modeling pipeline leading to phase clinical studies, manufacturing, and sales. -Bipolar (disease in high demand for new and alt. treatment) -Schizophrenia (disease in high demand for new and alt. treatment) -Borderline Personality Disorder ...

Pharma Connections Worldwide

Business Networking, Technology, Drug Development, Medical Devices, Healthcare
Looking for private equity investors for drug development, medical devices, nutraceuticals and healthcare IT technology

Relay Technology Management

Harnessing Software Analytics to Improve Drug Delivery Efficiency
In the next several years the pharmaceutical industry will hit a wall. The volume of data that must be considered to make informed decisions is increasing at an exponential rate and is becoming overwhelming. Current resources do not adequately aggregate both ...

Stemgent

Disease Diagnostic Group

Diagnostic tests for malaria
DDG replaces traditional chemical tests with a single reusable device for multiple diseases. It can be used by any patient, anywhere.

GNS Healthcare

Discovering what works in healthcare.

Renu Therapeutics

Novel proteins for treatment of ischemic injury
Renu is developing novel proteins to treat ischemic injury. Our lead program, Intestinal Trefoil Factor (ITF), is a secreted protein with a known role in mucosal repair. Renu has shown that acute admin of recombinant ITF significantly reduces myocardial infarct ...

Embera NeuroTherapeutics

Novel treatment for smoking cessation and cocaine dependence
Embera is developing a patent-pending drug combination, EMB-001, that addresses significant unmet needs in smoking cessation and cocaine dependence. Embera is advancing its lead product for smoking cessation (a $1.9B worldwide market), based on positive results ...

Sevo Nutraceuticals

Leader in highly efficacious, science-backed nutraceuticals
PERCEPTIV® protects against the normal cognitive decline associated with aging and is clinically proven to enhance mental clarity, help improve memory, and help restore a healthy mood. PERCEPTIV® is a patented formula based on research that was funded by UMASS ...

iSpecimen

iSpecimen’s technology provides data-rich human biospecimens to medical researchers.

Rodin Therapeutics

Novel treatments for Alzheimer's disease
Rodin Therapeutics is leveraging groundbreaking biology and a quantum-mechanics inspired chemistry approach to develop new drugs for Alzheimer's disease. Patients with Alzheimer's Disease and other causes of cognitive decline lack effective therapies to reverse ...

Daktari Diagnostics

Daktari Diagnostics manufactures diagnostic medical products for the developing world.

Vertex Pharmaceuticals

The Science of Possibility. Vertex creates new possibilities in medicine to cure diseases and improve people's lives.

Zepteon

Selectively purify nonfucosylated antibodies
Zepteon has developed a breakthrough antibody development and manufacturing technology that enables biopharmaceutical companies to evaluate and tune their drug potency. This is accomplished by separating high potency antibodies (nonfucosylated) from complex mixtures ...

Reify Health

Building a more creative healthcare system.
Reify Health is building a new type of clinical research site that uses technology to make clinical trials more predictable and economical for life sciences companies.

Vaxess Technologies

Using Silk To Create Heat Stable Vaccines
Vaxess's proprietary technology uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration, unlike existing products. Vaxess strives to lower the cost of distribution and increase access to vaccines for people around ...

LabMinds

Mass Customization for Liquids
"LabMinds Revo will revolutionize one of the most thankless but critical tasks in wetlab biology." - PI & Customer at Memorial Sloan Kettering Revo automates solution preparation for wet labs, a repetitive process using up 1,000,000h of researcher time every day, ...

LabCloud

Better and Accessible Laboratory Software
LabCloud is dedicated to the implementation of laboratory software designed to bring out the full capabilities of Research and Development organizations by providing them with an integrated cloud or server based system to effectively manage their data, inventory ...

Wyss Institute at Harvard

A new model for innovation, collaboration, and technology translation
The Wyss Institute at Harvard University seeks to uncover Nature's design principles and to harness this knowledge to develop new bioinspired materials and devices to improve healthcare and enhance sustainability.

Boreal Therapeutics

Next Gen Antibody Platform
Boreal is developing a new antibody discovery technology that involves breaking tolerance in vivo to generate broader antibody diversity against tough to immunize drug targets, like GPCRs and other transmembrane proteins.

Biotricity Biomedical

Biological batteries for lasting medical implants
Our first product, currently under development, is the EpiVoltTM biogenerator. It is an implantable electric generator designed to power implanted medical devices. It is unique among energy power sources either on the market or in development.

Hydra Biosciences

American Well

Seventh Sense Biosystems

SpringLeaf Therapeutics

ReadCube

Organizing Academic Literature
ReadCube develops software to make the world of research more accessible and connected. Its free ReadCube desktop application for PC and Mac helps researchers in any discipline easily organize and manage existing article libraries, and discover new literature through ...

Neurophage Pharmaceuticals

Semprus BioSciences

Snapdragon Chemistry

Next-Gen Flow Chemistry Company
Snapdragon Chemistry, Inc. is a leader in continuous flow services and solutions. Our company is catalyzing the transformation of how research and development is being done across a series of industries where organic chemistry underpins product development. We ...

Moderna Therapeutics

Intellia Therapeutics

TREATING GENETIC DISEASE
CRISPR/Cas9 for human therapeutics

Innerscope Research

Innerscope is the leading global consumer research firm specializing in measuring the emotional connection between brands, products and consumers.

OvaScience

Improving fertility through science
Fertility decreases with age. Mitochondria are the primary source of cellular energy from within eggs, and this energy is a key determinant of egg quality. It has been demonstrated that the number and function of mitochondria decrease with age. With OvaScience’s ...

Ryzome

Efficient and less expensive science market
Currently, in the antibody market, there is massive source obfuscation which suppliers use to artificially increase prices. This is costing the scientific community hundreds of millions of dollars each year and limiting information sharing. Ryzome fixes this problem. As ...

Acetylon Pharmaceuticals

Sirtris Pharmaceuticals

Helicos BioSciences

E_Nerv Tech

Pain Prevention Appliance
Our product is a non invasive device which when placed on the back of a patients neck will block all pain signals from being transmitted to the brain. This product will be sold to hospitals as a tool which will increase their surgery success rates while lowering ...

Convergent Dental

Instromedix

Invivo Therapeutics

Living Proof

Firefly BioWorks

Good Start Genetics

Good Start Genetics provides state-of-the-art accurate genetic carrier screening tests. Learn more about our product & carrier screening below.

Oncolinx

Oncolinx is developing next-generation, targeted cancer therapeutics.
Oncolinx is developing the next generation of antibody-drug conjugates (ADCs)--powerful, targeted cancer therapies that are more effective and have dramatically fewer side effects than current methods of cancer treatment. These therapies can be targeted to nearly ...

Genocea Biosciences

Hemera Biosciences

Treatment for Dry Macular Degeneration
Hemera Biosciences has developed a unique treatment for dry age related macular degeneration (AMD). By understanding the genetic background of the disease, which is linked to a part of the immune system called the complement cascade, we have created a modification ...

JB Therapeutics

KnipBio

A novel biotechnology to support a sustainable tomorrow

kwiKBio

Crowd-sourcing curing disease
kwiKBio empowers more than 10 million citizen scientists to become superheroes to cure disease, sooner rather than later. Without specialized scientific training, users simply choose what disease they want to work on.  The system rapidly leads them to a next ...